drugset / Trial / NCT00018863

Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)

NCT00018863 ↗

RandomizedDouble-blindTreatment

Summary

This research focuses on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in very young children. The medication being used is methylphenidate (Ritalin); it is being studied to determine its safety and how well it works to treat ADHD in preschool-age children (3-5.5 year olds).

Timeline

Start
2001-04-01
Primary completion
2006-03-31
Completion
2006-11-30

Outcome

Met primary endpoint

paper Compared with placebo, significant decreases in ADHD symptoms were found on MPH at 2.5 mg (p<.01), 5 mg (p<.001), and 7.5 mg (p<.001) t.i.d. doses PMID 17023867 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule 1.25 mg —
Subject Methylphenidate Small molecule 2.5 mg —
Subject Methylphenidate Small molecule 5 mg —
Subject Methylphenidate Small molecule 7.5 mg —